Anna Maria Dennen

Anna Maria Dennen serves as a Contracting Officer responsible for managing the acquisition lifecycle for pharmaceutical and medicinal manufacturing requirements within her organization. She ensures compliance with federal procurement regulations while delivering mission-critical supplies and services that support public health initiatives. Her portfolio primarily consists of full and open competitions under the Federal Acquisition Regulation, with a focus on complex, technical procurements requiring rigorous evaluation of manufacturing capabilities, quality control systems, and cGMP compliance. Dennen oversees solicitations ranging from basic raw material procurement to finished pharmaceutical products, ensuring alignment with federal standards and supply chain resilience objectives. While no specific contractor relationships are currently identifiable due to data limitations, Dennen’s procurement patterns indicate engagement with a broad spectrum of regulated manufacturers, including both large-scale pharmaceutical producers and specialized chemical processors. Her contracting approach emphasizes competitive bidding, transparent evaluation criteria, and strict adherence to technical specifications outlined in performance work statements. She maintains professional relationships with vendors capable of meeting stringent regulatory requirements under FDA oversight and ISO standards. Dennen’s contracting activity reflects a strong preference for full and open competition, with 100% of her awards issued without set-aside designations. This indicates a focus on technical capability and cost-effectiveness over socioeconomic preferences, though her work remains fully compliant with all applicable small business statutes. Her approach suggests a prioritization of product quality, regulatory adherence, and supply chain reliability over socioeconomic targeting. Her primary procurement focus lies in NAICS 325411 (Medicinal and Botanical Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), reflecting deep expertise in the production of active pharmaceutical ingredients, compounded medications, and standardized drug formulations. She routinely evaluates vendors on manufacturing process validation, batch traceability, stability testing, and Good Manufacturing Practice compliance, demonstrating specialized knowledge in the pharmaceutical supply chain and regulated production environments.